WinstonWınston
Back
Stock

Celanese Corporation

CE
20
Chemicals · Basic Materials
Also trades as: 0HUR.L GBP 0.47 (-0.06%)
Price
$47.17
-0.05 (-0.11%)
Market Cap
$5.18B
Winston Score
20
Winston is worried
Weak fundamentals across most pillars.
Data as of Oct 23, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Weak
6/30
Growth
Weak
2/20
Cash Flow
Weak
2/10
Stability
Weak
1/10
Valuation
Data not available
0/10
Ownership
Good
8/15
Dividends
Weak
1/5

20 of 100 counted points = Winston Score 20.

Track this stock — start free trial

Share count falling — buybacks

−2.3% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 112.1M (2021) → 109.5M (2025)

§Winston Score History

The full picture

Celanese is a chemical company that makes specialty materials used in everyday products like cars, electronics, medical devices, and food packaging. Its two main business segments are Engineered Materials — which produces tough plastics and polymers — and Acetyl Chain — which makes acetic acid and related chemicals used in paints, adhesives, and pharmaceuticals. Celanese is one of the largest producers of acetic acid in the world.

The company earns revenue by selling these chemicals and materials to manufacturers across many industries, operating plants in North America, Europe, and Asia. Its competitive position comes from large-scale, low-cost production and a broad portfolio of specialty formulations that are difficult for customers to easily replace. However, the current negative operating and returns margins reflect weak industrial demand and a heavy debt load taken on after its 2022 acquisition of DuPont's mobility and materials business — managing that debt while demand recovers is the central challenge facing the company today.

Politician Trades

1 trades / 12mo

0 Congressional buys and 1 sell on CE in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.7% YoY

YoY Growth Rate

Slow revenue growth

Reported EPS Growth

-37.4% YoY

Quarterly reporting periods ended:

30 Jun 2025: $1.82

30 Jun 2026: $1.14

Reported/statutory EPS, not adjusted or underlying earnings. One-off items can affect this figure. Provider rounding can affect the growth rate.

YoY Growth Rate

Reported EPS decreased year over year

R&D Spend

$125M/ year

→ Flat (-4% vs prior year)

1.3% of revenue

Below sector average (3%)

Steady R&D investment year-over-year

Insider Activity

9.1%ownership

↑ Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$2.6B cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Celanese Corporation is growing revenue at 9% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
22.5%
Thin — 22.5% gross margin
Profit after running costs
Operating Margin
10.0%
Modest — 10.0% operating margin
Return on the money invested
ROCE
-4.1%
Weak — -4.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-2.3%
Shrinking sales (-2.3% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
7.3%
Modest free cash flow (7.3%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
2.96
Heavy debt load (2.96)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.25%
Small dividend — 0.25% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial